These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5137334)

  • 1. Studies on bladder stone disease in Thailand. XV. Factors affecting the solubility of calcium oxalate.
    Chulkaratana S; Van Reen R; Valyasevi A
    Invest Urol; 1971 Nov; 9(3):246-50. PubMed ID: 5137334
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of bladder stone disease in Thailand. XVI. Effect of 4-hydroxy-L-proline and orthophosphate supplementations on urinary composition and crystalluria.
    Valyasevi A; Dhanamitta S; Van Reen R
    Am J Clin Nutr; 1973 Nov; 26(11):1207-11. PubMed ID: 4748180
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on bladder stone disease in Egyptian children. VIII. Biochemical studies of the urine.
    Loutfi AH; Van Reen R; Abdel Hamid G
    J Egypt Med Assoc; 1978; 61(9-10):621-31. PubMed ID: 262249
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of bladder stone disease in Thailand. XVII. Effect of exogenous source of oxalate on crystalluria.
    Valyasevi A; Dhanamitta S
    Am J Clin Nutr; 1974 Aug; 27(8):877-82. PubMed ID: 4846411
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxalate metabolism. 3.
    Hagler L; Herman RH
    Am J Clin Nutr; 1973 Sep; 26(9):1006-10. PubMed ID: 4580435
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary supersaturation with calcium oxalate before and during orthophosphate therapy.
    Burdette DC; Thomas WC; Finlayson B
    J Urol; 1976 Apr; 115(4):418-22. PubMed ID: 1263318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of bladder stone disease in Thailand. X. Effect of orthophosphate and nonfat dry milk supplementations on urine composition.
    Valyasevi A; Dhanamitta S; Van Reen R
    Am J Clin Nutr; 1969 Feb; 22(2):218-27. PubMed ID: 4304084
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of bladder stone disease in Thailand. IX. Effect of orthophosphate and fat-free powdered milk supplementations on the occurrence of crystalluria.
    Dhanamitta S; Valyasevi A; Van Reen R
    Am J Clin Nutr; 1967 Dec; 20(12):1387-91. PubMed ID: 5630469
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of bladder stone disease in Thailand. VI. Urinary studies in children, 2-10 years old, resident in a hypo- and hyperendemic area.
    Valyasevi A; Halstead SB; Dhanamitta S
    Am J Clin Nutr; 1967 Dec; 20(12):1362-8. PubMed ID: 6074673
    [No Abstract]   [Full Text] [Related]  

  • 10. Kidney and bladder stones in India.
    Teotia M; Teotia SP
    Postgrad Med J; 1977; 53 Suppl 2():41-51. PubMed ID: 882476
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies of phosphate therapy of urinary calculi].
    Kollwitz AA; Kracht H; Meier F
    Urologe; 1966 Jul; 5(4):168-71. PubMed ID: 4296919
    [No Abstract]   [Full Text] [Related]  

  • 12. [New aspects in the treatment of oxalate lithiasis (author's transl)].
    Hautmann R; Hering FJ; Terhorst B; Lutzeyer W
    Urologe A; 1976 Jul; 15(4):148-52. PubMed ID: 960323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of bladder stone disease in Thailand. XI. Effect of 4-hydroxy-L-proline and orthophosphate supplementations on crystalluria.
    Dhanamitta S; Valyasevi A; Van Reen R
    Am J Clin Nutr; 1970 Mar; 23(3):371-6. PubMed ID: 5436643
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on bladder stone disease in Egyptian children. VI. Crystalluria in the stone patients.
    Loutfi A; Van Reen R; Abdel-Hamid G
    J Egypt Med Assoc; 1974; 57(3-4):137-45. PubMed ID: 4430772
    [No Abstract]   [Full Text] [Related]  

  • 15. [Review. Physiopathology and treatment of urolothiasis].
    Fleisch H; Bisaz S
    Z Urol Nephrol; 1966 Nov; 59(11):785-800. PubMed ID: 4298145
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children.
    Milosević D; Batinić D; Konjevoda P; Blau N; Stambuk N; Nizić L; Vrljicak K; Batinić D
    J Chem Inf Comput Sci; 2003; 43(6):1844-7. PubMed ID: 14632431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orthophosphate treatment in calcium urolithiasis.
    Smith LH; Werness PG; VanDenBerg CJ; Wilson DM
    Scand J Urol Nephrol Suppl; 1980; 53():253-63. PubMed ID: 6938002
    [No Abstract]   [Full Text] [Related]  

  • 18. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitaxial considerations in urinary stone formation. II. The oxalate-phosphate system.
    Koutsoukos PG; Sheehan ME; Nancollas GH
    Invest Urol; 1981 Mar; 18(5):358-63. PubMed ID: 7203960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies of dietary influence on urinary oxalate in calcium oxalate stone formers].
    Arima K
    Hinyokika Kiyo; 1983 Dec; 29(12):1587-603. PubMed ID: 6687143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.